Seguir
Elaine Limkin
Elaine Limkin
Dirección de correo verificada de gustaveroussy.fr
Título
Citado por
Citado por
Año
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
R Sun, EJ Limkin, M Vakalopoulou, L Dercle, S Champiat, SR Han, ...
The Lancet Oncology 19 (9), 1180-1191, 2018
9332018
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
EJ Limkin, R Sun, L Dercle, EI Zacharaki, C Robert, S Reuzé, ...
Annals of Oncology 28 (6), 1191-1206, 2017
6302017
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners
S Reuzé, F Orlhac, C Chargari, C Nioche, E Limkin, F Riet, A Escande, ...
Oncotarget 8 (26), 43169, 2017
1432017
The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features
EJ Limkin, S Reuzé, A Carré, R Sun, A Schernberg, A Alexis, E Deutsch, ...
Scientific reports 9 (1), 4329, 2019
932019
Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma
M Gérard, A Corroyer-Dulmont, P Lesueur, S Collet, M Chérel, ...
Frontiers in medicine 6, 117, 2019
682019
A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer
A Schernberg, S Reuze, F Orlhac, I Buvat, L Dercle, R Sun, E Limkin, ...
European journal of nuclear medicine and molecular imaging 45, 187-195, 2018
352018
Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)
R Sun, S Champiat, L Dercle, S Aspeslagh, E Castanon, EJ Limkin, ...
European Journal of Cancer 84, 202-211, 2017
352017
Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae
R Sun, I Koubaa, EJ Limkin, I Dumas, E Bentivegna, E Castanon, S Gouy, ...
Oncotarget 9 (10), 9299, 2018
282018
45 or 50 Gy, which is the optimal radiotherapy pelvic dose in locally advanced cervical cancer in the perspective of reaching magnetic resonance image-guided adaptive …
R Mazeron, C Petit, E Rivin, E Limkin, I Dumas, P Maroun, P Annede, ...
Clinical Oncology 28 (3), 171-177, 2016
262016
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma
EJ Limkin, P Blanchard
The British Journal of Radiology 92 (1102), 20190068, 2019
172019
Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients
S Espenel, M Kissel, MA Garcia, A Schernberg, S Gouy, S Bockel, ...
Gynecologic Oncology 158 (2), 323-330, 2020
152020
Computational medical imaging (radiomics) and potential for immuno-oncology
R Sun, EJ Limkin, L Dercle, S Reuzé, EI Zacharaki, C Chargari, ...
Cancer radiotherapie: journal de la Societe francaise de radiotherapie …, 2017
142017
Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
EJ Limkin, I Dumas, ER Del Campo, C Chargari, P Maroun, P Annède, ...
Brachytherapy 15 (2), 169-176, 2016
122016
Radiation therapy in the Philippines: A challenge in resourcefulness
JPA Cañal, EJC Limkin
International Journal of Radiation Oncology, Biology, Physics 94 (1), 7-10, 2016
112016
Improving radiotherapy workflow through implementation of delineation guidelines & AI-based annotation
M Ung, A Rouyar-Nicolas, E Limkin, C Petit, T Sarrade, A Carre, G Auzac, ...
International Journal of Radiation Oncology, Biology, Physics 108 (3), e315, 2020
82020
Adjuvant or salvage radiation therapy for prostate cancer after prostatectomy: Current status, controversies and perspectives
M Terlizzi, EJ Limkin, Y Moukasse, P Blanchard
Cancers 14 (7), 1688, 2022
72022
Imagerie médicale computationnelle (radiomique) et potentiel en immuno-oncologie
R Sun, EJ Limkin, L Dercle, S Reuzé, EI Zacharaki, C Chargari, ...
Cancer/Radiothérapie 21 (6-7), 648-654, 2017
62017
Machine-learning-based radiomics MRI model for survival prediction of recurrent glioblastomas treated with bevacizumab
S Ammari, R Sallé de Chou, T Assi, M Touat, E Chouzenoux, A Quillent, ...
Diagnostics 11 (7), 1263, 2021
52021
Radiomics to predict response to immunotherapy: an imminent reality?
EJ Limkin, R Sun
Future Oncology 16 (23), 1673-1676, 2020
42020
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature
M Terlizzi, E Limkin, N Sellami, G Louvel, P Blanchard
Clinical and Translational Radiation Oncology 39, 100584, 2023
32023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20